Top Abstract Purchase Related
Home
>
Node
>
Subnode

XELOX plus Bevacizumab Chemotherapy for a Patient with Postoperative Recurrence of Colorectal Cancer Under Hemodialysis for Chronic Renal Failure

Takeda, T.; Miyake, M.; Tanaka, K.; Uemura, M.; Ikeda, M.; Maeda, S.; Yamamoto, K.; Hama, N.; Nishikawa, K.; Miyamoto, A.; Miyazaki, M.; Hirao, M.; Nakamori, S.; Sekimoto, M.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1594-1596

2015

ISSN/ISBN: 0385-0684
PMID: 26805107
Document Number: 682261
We report the case of a patient with a postoperative recurrence of colon cancer who received XELOX plus bevacizumab chemotherapy whilst undergoing hemodialysis. A 73-year-old man had been receiving maintenance hemodialysis for 9 years due to chronic renal failure. At 64 years old, a Hartmann's operation and a posterior segment and segment 3 partial liver resection were performed for sigmoid colon cancer and metastatic liver cancer. Three years 1 months after surgery, local recurrence at the liver invading into the right lung was detected. XELOX plus bevacizumab chemotherapy was administered. After 16 courses of treatment, tumor control was achieved. Chemotherapy with molecular target drugs is currently recommended for advanced/metastatic colorectal cancer; however, a standardized strategy for hemodialysis patients is not established. As the number of hemodialysis patients receiving chemotherapy for some cancers is likely to increase in the future, it will be necessary to consider chemotherapy strategies for hemodialysis patients.

Document emailed within 1 workday
Secure & encrypted payments

Kamata, H.; Asano, K.; Soejima, K.; Shirahata, T.; Nakatani, M.; Inamoto, H.; Iketani, O.; Yamayoshi, Y.; Tanigawara, Y.; Ishizaka, A. 2009: Appropriate hemodialysis scheduling based on therapeutic drug monitoring of carboplatin in a patient with lung cancer and chronic renal failure Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1529-1532
Lu, G.-c.; Fang, F.; Li, D.-c. 2010: Efficacy and toxicity analysis of XELOX and FOLFOX4 regimens as adjuvant chemotherapy for stage IIi colorectal cancer Zhonghua Zhong Liu Za Zhi 32(2): 152-155
Soga, Y.; Ito, D.; Asano, H.; Go, M.; Iwai, M.; Okada, K.; Matsuoka, T.; Adachi, S.; Usami, E.; Kimura, M.; Nakao, T.; Yoshimura, T.; Yasuda, T.; Ogawa, T.; Iwaki, A. 2013: Continuation of chemotherapy with bevacizumab for advanced and recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(10): 1341-1345
Matsumoto, R.; Kuroda, T.; Yamada, H.; Hasegawa, K.; Mamiya, Y.; Kon, A. 2009: Chemotherapy with bevacizumab (BV)+modified FOLFOX6 for unresectable colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2207-2209
Ito, S.; Ichikawa, R.; Kure, K.; Honjo, K.; Aoki, J.; Okazawa, Y.; Mizukoshi, K.; Ro, H.; Kawai, M.; Takehara, K.; Okubo, H.; Ishiyama, S.; Sugimoto, K.; Komiyama, H.; Takahashi, M.; Yaginuma, Y.; Kojima, Y.; Goto, M.; Tomiki, Y.; Sakamoto, K. 2014: A case of cecum colon cancer with lymph node metastasis successfully treated with XELOX plus bevacizumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(11): 1425-1428
Bannura, G.; Melo, C.; Villamán, J.; Muñoz, M.; Levy, I. 1999: Non-specific cecal ulcer in a patient with chronic renal failure in hemodialysis treatment. Case report Revista Medica de Chile 127(5): 595-599
Iwasaki, A.; Tanizaki, A.; Ohbayashi, Y.; Miyake, M.; Nagahata, S.; Takahashi, N. 2000: Chemotherapy with nedaplatin for an oral floor cancer patient undergoing chronic hemodialysis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(14): 2231-2234
Imaizumi, H.; Ishibashi, K.; Okada, N.; Tajima, Y.; Amano, K.; Hatano, S.; Kuwabara, K.; Sobajima, J.; Ishiguro, T.; Ohsawa, T.; Kumamoto, K.; Kumagai, Y.; Haga, N.; Ishida, H. 2012: Clinical outcomes in refractory colorectal cancer patients with wild-type K-ras treated with bevacizumab and oxaliplatin-based chemotherapy as a first-line treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2185-2188
Tan, S.J.; Juan, Y.H.; Fu, P.T.; Yu, M.H.; Lai, H.C. 2010: Chemotherapy with low-dose bevacizumab and carboplatin in the treatment of a patient with recurrent cervical cancer European Journal of Gynaecological Oncology 31(3): 350-353
Lin, C.-P.; Chi, P. 2009: Clinical study of postoperative intraperitoneal chemotherapy combined with systemic chemotherapy for serosa-involved colorectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 12(3): 257-260
Egorova, E.K.; Mar'in, D.S.; Shutova, N.A.; Galstian, G.M.; Savenko, T.A.; Kremenetskia, A.M.; Kravchenko, S.K.; Magomedova, A.U.; Kovalenko, A.V.; Kaplanskaia, I.B.; Samoĭlova, R.S.; Kliasova, G.A.; Kozlova, S.I. 2008: Intensive chemotherapy of diffuse large B-cell lymphosarcoma in a female patient with chronic renal failure and afunctional left kidney Terapevticheskii Arkhiv 80(7): 57-59
Shigoka, M.; Enomoto, M.; Wada, T.; Mazaki, J.; Kuwabara, H.; Ishizaki, T.; Ishibashi, Y.; Nagakawa, Y.; Katsumata, K.; Tsuchida, A. 2019: A Case of a Patient with Locally Recurrent Rectal Cancer Who Underwent Surgical Resection after Chemotherapy with FOLFOXIRI plus Bevacizumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(4): 796-798
Kashiwagi, S.; Ishihara, S.; Ishii, M.; Asano, Y.; Watanabe, M.; Morisaki, T.; Aomatsu, N.; Noda, S.; Kawajiri, H.; Nakano, T.; Kawakami, N.; Mitsukawa, Y.; Takashima, T.; Onoda, N.; Ishikawa, T.; Hirakawa, K. 2013: Case of a patient with inflammatory breast cancer who responded to preoperative chemotherapy with paclitaxel plus bevacizumab and could subsequently undergo surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2384-2386
Kajiyama, H.; Kuroiwa, T.; Ueki, K.; Kanai, H.; Maezawa, A.; Yano, S.; Nojima, Y.; Naruse, T. 2000: Hypercalcemia induced by metastatic bone cancer in a patient with chronic renal failure Clinical Nephrology 54(4): 347-350
Kawahara, H.; Hirai, K.; Ashikaga, K.; Yamada, Y.; Kimura, C.; Kuroda, H.; Sato, K.; Ono, M.; Aoki, T. 1994: The usefulness of pre- and immediately postoperative chemotherapy in colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(8): 1215-1219
Ogata, Y.; Torigoe, S.; Matono, K.; Sasatomi, T.; Ishibashi, N.; Shida, S.; Ohkita, A.; Fukumitu, T.; Mizobe, T.; Ikeda, S.; Ogo, S.; Ozasa, H.; Shirouzu, K. 2007: Oral fluoropyrimidines may not reduce the risk of postoperative recurrence in colorectal cancer associated with mesenteric lymph node metastasis International Surgery 92(6): 314-319
Karacetin, D.; Yalcin, B.; Okten, B.; Ozturk, S.; Maral, O.; Incekara, O. 2009: Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 14(4): 605-608
Kodaira, S. 1997: The current status of postoperative adjuvant chemotherapy for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(10): 1230-1238
Takano, S.; Moriguchi, M.; Seki, N.; Higaki, T.; Watanabe, Y.; Takahashi, T.; Ito, Y.; Oishi, H.; Nakata, Y.; Kono, S. 1994: The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(13): 2176-2178
Matoba, S.; Sawada, T.; Toda, S.; Moriyama, J.; Yokoyama, T.; Ehara, K.; Mine, S.; Ueno, M.; Kinoshita, Y.; Matsuda, M.; Tsutsumi, K.; Hashimoto, M.; Udagawa, H.; Watanabe, G.; Katori, H.; Hayashi, M.; Igarashi, M.; Ito, T.; Hasebe, S.; Sato, M. 2008: Modified FOLFOX6 in a patient on hemodialysis with metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(4): 673-675